-
1
-
-
0035818044
-
Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin
-
Kazatchkine MD, Kaveri S. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med. 2001; 345:747-55.
-
(2001)
N Engl J Med
, vol.345
, pp. 747-755
-
-
Kazatchkine, M.D.1
Kaveri, S.2
-
2
-
-
0032124204
-
Self-reactive antibodies (natural autoantibodies) in healthy individuals
-
Lacroix-Desmazes S, Kaveri SV, Mouthon L et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods. 1998; 216:117-37.
-
(1998)
J Immunol Methods
, vol.216
, pp. 117-137
-
-
Lacroix-Desmazes, S.1
Kaveri, S.V.2
Mouthon, L.3
-
3
-
-
0032707209
-
Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Present status and practical therapeutic guidelines
-
Dalakas MC. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines. Muscle Nerve. 1999; 22:1479-97.
-
(1999)
Muscle Nerve
, vol.22
, pp. 1479-1497
-
-
Dalakas, M.C.1
-
4
-
-
0015514084
-
Giardiasis with malabsorption in X-linked agammaglobulinemia
-
Ochs HD, Ament ME, Davis SD. Giardiasis with malabsorption in X-linked agammaglobulinemia. N Engl J Med. 1972; 287:341-2.
-
(1972)
N Engl J Med
, vol.287
, pp. 341-342
-
-
Ochs, H.D.1
Ament, M.E.2
Davis, S.D.3
-
6
-
-
0022483563
-
Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinemia
-
Roifman CM, Rao CP, Lederman HM et al. Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinemia. Am J Med. 1986; 80:590-4.
-
(1986)
Am J Med
, vol.80
, pp. 590-594
-
-
Roifman, C.M.1
Rao, C.P.2
Lederman, H.M.3
-
7
-
-
0032976666
-
Common variable immunodeficiency: Clinical and immunological features of 248 patients
-
Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999; 92:34-48.
-
(1999)
Clin Immunol
, vol.92
, pp. 34-48
-
-
Cunningham-Rundles, C.1
Bodian, C.2
-
8
-
-
0023237564
-
High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinemia and chronic lung disease
-
Roifman CM, Levinson H, Gelfand EW. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinemia and chronic lung disease. Lancet. 1987; 1:1075-7.
-
(1987)
Lancet
, vol.1
, pp. 1075-1077
-
-
Roifman, C.M.1
Levinson, H.2
Gelfand, E.W.3
-
9
-
-
0033511446
-
Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients
-
Quartier P, Debre M, De Blic J et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr. 1999; 134:589-96.
-
(1999)
J Pediatr
, vol.134
, pp. 589-596
-
-
Quartier, P.1
Debre, M.2
De Blic, J.3
-
10
-
-
0035822661
-
The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia
-
Eijkhout HW, van der Meer JWM, Kallenberg CGM et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. Ann Intern Med. 2001; 135:165-74.
-
(2001)
Ann Intern Med
, vol.135
, pp. 165-174
-
-
Eijkhout, H.W.1
Van Der Meer, J.W.M.2
Kallenberg, C.G.M.3
-
11
-
-
0026001744
-
Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy
-
Chapel H, Griffiths H, Brennan V et al. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy. Immunol Invest. 1991; 20:187-91.
-
(1991)
Immunol Invest
, vol.20
, pp. 187-191
-
-
Chapel, H.1
Griffiths, H.2
Brennan, V.3
-
12
-
-
0026715164
-
Predictors of infection in chronic lymphocytic leukaemia (CLL)
-
Griffiths H, Lea J, Bunch C et al. Predictors of infection in chronic lymphocytic leukaemia (CLL). Clin Exp Immunol. 1992; 89:374-7.
-
(1992)
Clin Exp Immunol
, vol.89
, pp. 374-377
-
-
Griffiths, H.1
Lea, J.2
Bunch, C.3
-
13
-
-
0028133629
-
The use of intravenous immune globulin in multiple myeloma
-
Chapel HM, Lee M. The use of intravenous immune globulin in multiple myeloma. Clin Exp Immunol. 1994; 97(Suppl 1):21-4.
-
(1994)
Clin Exp Immunol
, vol.97
, Issue.SUPPL. 1
, pp. 21-24
-
-
Chapel, H.M.1
Lee, M.2
-
14
-
-
0028901880
-
Immunological factors and risk of infection in plateau phase myeloma
-
Hargreaves RM, Lea JR, Griffiths H et al. Immunological factors and risk of infection in plateau phase myeloma. J Clin Pathol. 1995; 48:260-6.
-
(1995)
J Clin Pathol
, vol.48
, pp. 260-266
-
-
Hargreaves, R.M.1
Lea, J.R.2
Griffiths, H.3
-
15
-
-
0030321441
-
Prophylaxis against infections with low-dose intravenous immunoglobulins (FVIG) in chronic lymphocytic leukemia. Results of a crossover study
-
Molica S, Musto P, Chiurazzi F et al. Prophylaxis against infections with low-dose intravenous immunoglobulins (FVIG) in chronic lymphocytic leukemia. Results of a crossover study. Haematologica. 1996; 81:121-6.
-
(1996)
Haematologica
, vol.81
, pp. 121-126
-
-
Molica, S.1
Musto, P.2
Chiurazzi, F.3
-
16
-
-
0029019914
-
Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients
-
Crow ME. Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients. Am J Health-Syst Pharm. 1995; 52:803-11.
-
(1995)
Am J Health-Syst Pharm
, vol.52
, pp. 803-811
-
-
Crow, M.E.1
-
17
-
-
0031204924
-
Intravenous immunoglobulin in symptomatic and asymptomatic children with perinatal HIV infection
-
Olopoenia L, Young M, White D et al. Intravenous immunoglobulin in symptomatic and asymptomatic children with perinatal HIV infection. J Natl Med Assoc. 1997; 89:543-7.
-
(1997)
J Natl Med Assoc
, vol.89
, pp. 543-547
-
-
Olopoenia, L.1
Young, M.2
White, D.3
-
18
-
-
0023622087
-
Immunoglobulin therapy in bone marrow transplantation
-
Sullivan KM. Immunoglobulin therapy in bone marrow transplantation. Am J Med. 1987; 83:34-45.
-
(1987)
Am J Med
, vol.83
, pp. 34-45
-
-
Sullivan, K.M.1
-
19
-
-
0025102027
-
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation
-
Sullivan KM, Kopecky KJ, Jocom J et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med. 1990; 323:705-12.
-
(1990)
N Engl J Med
, vol.323
, pp. 705-712
-
-
Sullivan, K.M.1
Kopecky, K.J.2
Jocom, J.3
-
20
-
-
0019463420
-
High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
-
Imbach P, Barandun S, d'Apuzzo V et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981; 1(8232):1228-31.
-
(1981)
Lancet
, vol.1
, Issue.8232
, pp. 1228-1231
-
-
Imbach, P.1
Barandun, S.2
D'Apuzzo, V.3
-
21
-
-
8944225498
-
Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
-
George JN, Woolf SH, Raskob GE et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88:36-40.
-
(1996)
Blood
, vol.88
, pp. 36-40
-
-
George, J.N.1
Woolf, S.H.2
Raskob, G.E.3
-
22
-
-
0030907223
-
Experience with IVIg in the treatment of patients with myasthenia gravis
-
Dalakas MC. Experience with IVIg in the treatment of patients with myasthenia gravis. Neurology. 1997; 48(Suppl 1):64-9.
-
(1997)
Neurology
, vol.48
, Issue.SUPPL. 1
, pp. 64-69
-
-
Dalakas, M.C.1
-
23
-
-
0031034253
-
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome
-
Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet. 1997; 349:225-30.
-
(1997)
Lancet
, vol.349
, pp. 225-230
-
-
-
24
-
-
0029128453
-
Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin
-
Choudhary PP, Hughes RAC. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. Q J Med. 1995; 88:493-502.
-
(1995)
Q J Med
, vol.88
, pp. 493-502
-
-
Choudhary, P.P.1
Hughes, R.A.C.2
-
25
-
-
0032423145
-
Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin
-
Hahn AF. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Neurology. 1998; 51:16-21.
-
(1998)
Neurology
, vol.51
, pp. 16-21
-
-
Hahn, A.F.1
-
26
-
-
84860981816
-
Cells involved in immune responses
-
Hunt R.
-
Bowers W. Cells involved in immune responses. In: Hunt R. Microbiology and Immunology On-Line. http://www.med. sc.edu:85/bowers/immune%20cells.htm. Accessed 2005 May 26.
-
Microbiology and Immunology On-Line
-
-
Bowers, W.1
-
27
-
-
0034769492
-
Antibody-directed therapy: Past, present, and future
-
Gelfand EW. Antibody-directed therapy: past, present, and future. J Allergy Clin Immunol. 2001; 108(4 Suppl):S111-6.
-
(2001)
J Allergy Clin Immunol
, vol.108
, Issue.4 SUPPL.
-
-
Gelfand, E.W.1
-
28
-
-
0030929805
-
Fc receptor biology
-
Daëron M. Fc receptor biology. Annu Rev Immunol. 1997; 15:203-34.
-
(1997)
Annu Rev Immunol
, vol.15
, pp. 203-234
-
-
Daëron, M.1
-
29
-
-
0022644378
-
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody
-
Clarkson SB, Bussel JB, Kimberly RP et al. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N Engl J Med. 1986; 314:1236-9.
-
(1986)
N Engl J Med
, vol.314
, pp. 1236-1239
-
-
Clarkson, S.B.1
Bussel, J.B.2
Kimberly, R.P.3
-
30
-
-
0027504398
-
Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura
-
Debré M, Bonnet MC, Fridman WH et al. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet. 1993; 342:945-9.
-
(1993)
Lancet
, vol.342
, pp. 945-949
-
-
Debré, M.1
Bonnet, M.C.2
Fridman, W.H.3
-
31
-
-
0035910392
-
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
-
Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001; 291:484-6.
-
(2001)
Science
, vol.291
, pp. 484-486
-
-
Samuelsson, A.1
Towers, T.L.2
Ravetch, J.V.3
-
32
-
-
0030892121
-
Intravenous immune globulin therapy for neurologic diseases
-
Dalakas MC. Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med. 1997; 126:721-30.
-
(1997)
Ann Intern Med
, vol.126
, pp. 721-730
-
-
Dalakas, M.C.1
-
33
-
-
0022485186
-
The treatment of Kawasaki syndrome with intravenous gamma globulin
-
Newburger JW, Takahashi M, Burns JC et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986; 315:341-7.
-
(1986)
N Engl J Med
, vol.315
, pp. 341-347
-
-
Newburger, J.W.1
Takahashi, M.2
Burns, J.C.3
-
34
-
-
0032924155
-
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - A comparative observational study
-
The Canadian Streptococcal Study Group
-
Kaul R, McGeer A, Norrby-Teglund A et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999; 28:800-7.
-
(1999)
Clin Infect Dis
, vol.28
, pp. 800-807
-
-
Kaul, R.1
McGeer, A.2
Norrby-Teglund, A.3
-
35
-
-
0036226952
-
Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders
-
Larroche C, Chanseaud Y, Garcia de la Pena-Lefebvre P et al. Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders. Biodrugs. 2002; 15:47-55.
-
(2002)
Biodrugs
, vol.15
, pp. 47-55
-
-
Larroche, C.1
Chanseaud, Y.2
Garcia De La Pena-Lefebvre, P.3
-
36
-
-
0024314008
-
Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease
-
Leung DY, Cotran RS, Kurt-Jones E et al. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet. 1989; 2:1298-1302.
-
(1989)
Lancet
, vol.2
, pp. 1298-1302
-
-
Leung, D.Y.1
Cotran, R.S.2
Kurt-Jones, E.3
-
37
-
-
0032588204
-
I.V. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome
-
Sharief MK, Ingram DA, Swash M et al. I.V. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome. Neurology. 1999; 52:1833-8.
-
(1999)
Neurology
, vol.52
, pp. 1833-1838
-
-
Sharief, M.K.1
Ingram, D.A.2
Swash, M.3
-
38
-
-
0028113940
-
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments
-
Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest. 1994; 94:1729-35.
-
(1994)
J Clin Invest
, vol.94
, pp. 1729-1735
-
-
Basta, M.1
Dalakas, M.C.2
-
39
-
-
0029920575
-
Kawasaki syndrome: Immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin
-
Leung DY. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin. Clin Exp Immunol. 1996; 104(Suppl 1):49-54.
-
(1996)
Clin Exp Immunol
, vol.104
, Issue.SUPPL. 1
, pp. 49-54
-
-
Leung, D.Y.1
-
40
-
-
0034775211
-
Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses
-
Schlievert PM. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J Allergy Clin Immunol. 2001; 108(4 Suppl):S107-10.
-
(2001)
J Allergy Clin Immunol
, vol.108
, Issue.4 SUPPL.
-
-
Schlievert, P.M.1
-
41
-
-
0021221197
-
Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin
-
Sultan Y, Kazatchkine MD, Maisonneuve P et al. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. 1984; 2:765-8.
-
(1984)
Lancet
, vol.2
, pp. 765-768
-
-
Sultan, Y.1
Kazatchkine, M.D.2
Maisonneuve, P.3
-
42
-
-
0026684691
-
Can intravenous immunoglobulin treatment regulate autoimmune responses?
-
Kaveri SV, Dietrich G, Kazatchkine MD. Can intravenous immunoglobulin treatment regulate autoimmune responses? Semin Hematol. 1992; 29(3 Suppl 2):64-71.
-
(1992)
Semin Hematol
, vol.29
, Issue.3 SUPPL. 2
, pp. 64-71
-
-
Kaveri, S.V.1
Dietrich, G.2
Kazatchkine, M.D.3
-
43
-
-
0025254342
-
Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies
-
Dietrich G, Kazatchkine MD. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest. 1990; 85:620-5.
-
(1990)
J Clin Invest
, vol.85
, pp. 620-625
-
-
Dietrich, G.1
Kazatchkine, M.D.2
-
44
-
-
0033590571
-
Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases
-
Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med. 1999; 340:227-8.
-
(1999)
N Engl J Med
, vol.340
, pp. 227-228
-
-
Yu, Z.1
Lennon, V.A.2
-
45
-
-
23844462835
-
Pharmacy considerations for the use of IGIV therapy
-
Shah S. Pharmacy considerations for the use of IGIV therapy. Am J Health-Syst Pharm. 2005; 62(Suppl 3):S5-11.
-
(2005)
Am J Health-Syst Pharm
, vol.62
, Issue.SUPPL. 3
-
-
Shah, S.1
-
46
-
-
0032538505
-
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
-
Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998; 282:490-3.
-
(1998)
Science
, vol.282
, pp. 490-493
-
-
Viard, I.1
Wehrli, P.2
Bullani, R.3
|